Back
UPM-Kymmene Oyj Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
40
UPMKF
UPM-Kymmene Oyj
Last Price:
26.92
Seasonality Move:
-2.25%
Sell
1
AGIO
Agios Pharmaceuticals
Last Price:
39.12
Seasonality Move:
12.89%
Sell
40
UPM-Kymmene Oyj (UPMKF)
is a Sell
Is UPM-Kymmene Oyj a Buy, Sell or Hold?
- The current UPM-Kymmene Oyj [UPMKF] share price is $27.44. The Score for UPMKF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- UPMKF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.17. The Score for AGIO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
UPMKF Stock Price Chart
What is UPM-Kymmene Oyj's stock price today?
-
The UPM-Kymmene Oyj share price today is $27.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UPMKF is experiencing selling pressure, which indicates risk of future bearish movement.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
UPMKF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 47.99 | Sell |
| Chaikin Money Flow: | -1135 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.42 - 28.2) | Buy |
| Bollinger Bands (100): | (28.38 - 33.46) | Sell |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.34 | Sell |
| Relative Strength Index (14 RSI): | 26.34 | Sell |
| Chaikin Money Flow: | -1550643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.73 - 60.93) | Sell |
| Bollinger Bands (100): | (42.01 - 53.19) | Sell |
UPMKF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.49 | Sell |
| 20-day SMA: | 27.23 | Buy |
| 50-day SMA: | 29.11 | Sell |
| 200-day SMA: | 32.85 | Sell |
| 8-day EMA: | 27.51 | Sell |
| 20-day EMA: | 27.56 | Sell |
| 50-day EMA: | 28.82 | Sell |
| 200-day EMA: | 31.94 | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.89 | Sell |
| 20-day SMA: | 54.55 | Sell |
| 50-day SMA: | 49.66 | Sell |
| 200-day SMA: | 41.9 | Sell |
| 8-day EMA: | 48.9 | Sell |
| 20-day EMA: | 52.35 | Sell |
| 50-day EMA: | 50.92 | Sell |
| 200-day EMA: | 42.82 | Sell |
UPM-Kymmene Oyj Earnings Growth & UPMKF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
UPM-Kymmene Oyj Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||